CONTINUE TO SITE
OR WAIT 15 SECS
Search
Spotlight
COVID-19 Update
Analytics
Development
Downstream Processing
Manufacturing
Outsourcing
Quality/GMPs
Upstream Processing
2020 Bio/Pharma Virtual Congress
COVID-19 Update
Analytics
Development
Downstream Processing
Manufacturing
Outsourcing
Quality/GMPs
Upstream Processing
2020 Bio/Pharma Virtual Congress
Topic
View More
Analytical Methods
BioBusiness
Cell Culture/Fermentation
Continuous Processing
Drug Delivery
Fill/Finish
Formulation
Process Chromatography
Process Control/PAT
Process Development
QA/QC
Separation and Purification
Single-Use Systems
Supply Chain
Analytical Methods
BioBusiness
Cell Culture/Fermentation
Continuous Processing
Drug Delivery
Fill/Finish
Formulation
Process Chromatography
Process Control/PAT
Process Development
QA/QC
Separation and Purification
Single-Use Systems
Supply Chain
News
All News
Top News
Bio/Pharma News
Industry News
Supplier News
Events
All News
Top News
Bio/Pharma News
Industry News
Supplier News
Events
Publications
All Publications
BioPharm International
All Publications
BioPharm International
Resources
Biopharma Insights
Sponsored eBooks
Sponsored Podcasts
Sponsored Videos
Whitepapers
Biopharma Insights
Sponsored eBooks
Sponsored Podcasts
Sponsored Videos
Whitepapers
Webcasts
Subscribe
Enews
Magazine
Enews
Magazine
Search
Spotlight
COVID-19 Update
Analytics
Development
Downstream Processing
Manufacturing
Outsourcing
Quality/GMPs
Upstream Processing
2020 Bio/Pharma Virtual Congress
Topic
See All >
Analytical Methods
BioBusiness
Cell Culture/Fermentation
Continuous Processing
Drug Delivery
Fill/Finish
Formulation
Process Chromatography
Process Control/PAT
Process Development
QA/QC
Separation and Purification
Single-Use Systems
Supply Chain
Part 2: Red Blood Cells and Platelets
June 1, 2003
Gail Sofer
Gail Sofer
BioPharm International
,
BioPharm International-06-02-2003,
Volume 2003 Supplement,
Issue 1
by Gail Sofer, BioReliance
Related Content:
Part 1: Skin, Bone, and Cells
BioPharm International's Virus Inactivation Series: A Preface
Part 4: Culture Media, Biotechnology Products, and Vaccines